Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,655   13.81  Index Moved Down -0.83%
TMO A A DGX Corporate Bonds Recreation Currently Hot Manufacturing 
United States GSPC USD ...  |  Check Insiders


Processing
Processing. Please wait...

Quest insider: Catherine Doherty

       

Catherine Doherty - Quest Insider Profile

Sr. VP of Clinical Franchises

Ms. Catherine T. Doherty serves as Senior Vice President Clinical Franchises of Quest Diagnostics Inc. She is responsible for overseeing the development of service offerings in the areas of cardiovascular, infectious disease, neurology, prescription drugs monitoring, women' health and general wellness. She also is responsible for the Care 360 connectivity program. From May 2011 to January 2013, she served as Senior Vice President, Physician services. From 2008 through May 2011 Ms. Doherty served as Vice President, Hospital Services. Prior to 2008, Ms. Doherty held a variety of positions of increasing responsibility since joining the Company in 1990, including Vice President, Office of the Chairman; Vice President, Finance and Administration for the Hospital business; Vice President, Investor Relations; and Chief Accounting Officer.
Age: 49  SVP Since 2013      

Management Efficency

The company has Return on Asset of 8.32 % which means that on every $100 spent on asset it made $8.32 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.37 % implying that it generated $15.37 on every 100 dollars invested.
The company has 3.4 B in debt with debt to equity (D/E) ratio of 0.8 which is OK given its current industry classification. Quest Diagnostics Inc has Current Ratio of 1.19 demonstrating that it is not liquid enough and may have problems to pay out its financial commitments when the payables are due.
    

Other Executives

Entity Summary

Quest Diagnostics Incorporated offer diagnostic testing information services in the United States and internationally. Quest Diagnostics Inc [DGX] is traded on New York Stock Exchange in USA. It is located in Madison, NJ and employs 41,000 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
DGX United States NYSE
Quest Diagnostics Inc
Benchmark S&P 500
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
    
Chance of
Bankruptcy
Less
Than
39%
In The Next
Two Years
Quest Diagnostics Inc has less than 39.38 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

Quest price boundaries

    
April 22 2013
 55.85 
  
 55.48 
(0.37)  Macroaxis: -0.6624888093106617 Down   0.66%  
Lowest period price (30 days)
May 21 2013
 60.94 
  
 61.39 
0.45  Macroaxis: 0.738431243846411 Up   0.74%  
Highest period price (30 days)
    

Promote Quest and Catherine Doherty

Follow Quest with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Quest to your reader
 

Today Change

 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 thisRed DGX DGX agains markets  0.44 % Macroaxis: 0.44 Moved Down  
 
 United States SP 500   0.83 % Macroaxis: 0.83 Moved Down  
 
 United States NYSE   0.94 % Macroaxis: 0.94 Moved Down  
 
 United States Russel   1.65 % Macroaxis: change 1.65 Moved Down  
 

Stock Performance

Shares Outstanding215.3 M
Number of Shares Shorted8.17 M


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium